Prognostic Significance of New Immunohistochemical Markers in Refractory Classical Hodgkin Lymphoma: A Study of 59 Cases

Danielle Canioni, Bénédicte Deau-Fischer, Pierre Taupin et al. · 2009

Read Prognostic Significance of New Immunohistochemical Markers in Refractory Classical Hodgkin Lymphoma: A Study of 59 Cases by Danielle Canioni, Bénédicte Deau-Fischer, Pierre Taupin et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0006341.txt.

Description

Most classical Hodgkin lymphoma patients are cured, but a significant minority fail first treatment. Danielle Canioni and colleagues tested new immunohistochemical markers in fifty-nine refractory cases in a 2009 PLOS ONE paper. No consensus exists on biological markers that add value beyond usual clinical parameters.

Stains that reveal proteins in tumor tissue were checked for prognostic significance. A reliable marker could flag high-risk patients for stronger or experimental therapy early. It could also spare low-risk patients excess toxicity. The study weighs candidate markers in the hardest cases. More work will be needed to prove which marks hold up in new groups of cases.

Catalog record

CREATORDanielle Canioni, Bénédicte Deau-Fischer, Pierre Taupin et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE36 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0006341

Browse the full library · About the Tower of Babel